PDEX Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 12.09%, SMA50 10.44%, SMA200 12.63%). The stock’s 14-day RSI is 66.74 (firm momentum), while the ATR of 2.0 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -36.41% below its high and over 90.37% above its low. Average 10-day trading volume of 29.33 thousand shares is in line with the 3-month average of 26.97 thousand, indicating normal recent market interest.

Pro-Dex, Inc. generated EPS of $3.40 over the past year. Five-year average earnings growth is 12.25%. The latest quarter delivered EPS of $0.62. The next quarter is forecast at $nan. Next year's EPS is expected at $49.02. Pro-Dex, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended October 30, 2025, missed forecasts by 24.0%. The prior quarter beat by -23.4%. Over the last six quarters, Apple has recorded several small beats. These include 31.43% in September 05, 2024.

Pro-Dex, Inc. has 3.26 million shares outstanding. The public float is 1.82 million shares, elevated short interest at 75.07% of float. This equals 252.81 thousand shares. The short ratio is 5.22 days. Institutional investors hold 51.37% of the float. Insiders own 35.94%. Swenson Nicholas John holds 927.18 thousand shares, CABILLOT RAYMOND E has 270.85 thousand shares and Van Kirk Richard Lee Jr has 48.91 thousand shares.

Pro-Dex, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $16.88. This means the shares are trading above this model’s fair value.

Pro-Dex, Inc. (NASDAQ:PDEX) closed at $47.18 USD, gaining $0.64 (1.38%) from the previous close of $46.54. The stock is currently mid-range between its 52-week high and low $23.47 and $70.26. With a market capitalization of about $153.90 million, Pro-Dex, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.06). Key stats such as the average daily volume over the past year has been around 30.67 thousand shares, volume is running light vs its 52-week average. Headquartered in Irvine, CA, Pro-Dex, Inc. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Richard Lee Van Kirk Jr., the company employs approximately 146 people and listed since August 07, 1986. Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide.

Pro-Dex, Inc. trades at a P/E ratio of 13.34, slightly below the S&P 500 average, with a price-to-sales ratio of 2.11 and a price-to-book ratio of 3.63 trading at moderately above to book value. The P/FCF stands at 24.81, also above market averages.

Our AI price prediction model suggests that Pro-Dex, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 12.51%, with price expected at $52.36 by April 03, 2026, within a range of $50.90 to $53.96 3-Month Outlook: Projected rise of 44.61%, reaching $67.30 by June 18, 2026, with a range of $65.63 to $69.47. 1-Year Outlook: Projected gain of 34.14%, with price at $62.43 by March 19, 2027, within a range of $59.38 to $65.36.

Pro-Dex, Inc. (NASDAQ:PDEX) shares are flat 8.45% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Pro-Dex, Inc. trading at a premium to the broader market with a P/E of 13.34. Our AI forecast model points to short-term strength (12.51% over two weeks), a medium-term rise (44.61% over three months), and a longer-term gain (34.14% over one year), with expected trading ranges indicating moderate volatility.